Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
about
B-cell activity in children with malariaIn vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzeesComplement and systemic lupus erythematosus.Complement and lupus: old concepts and new directions.New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.Complement and its breakdown products in SLE.Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell helpComplement deficiencies in humans and animals: links to autoimmunity.Immune complex assays: diagnostic and clinical application.Complement, C receptors, and immune complex disease.Serological markers of disease activity in systemic lupus erythematosus.Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).Does reduced erythrocyte C3b receptor (CR1) activity contribute to the pathogenesis of yersinia triggered reactive arthritis?A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.Binding of properdin to solid-phase immune complexes: critical role of the classical activation pathway of complement.Do Plasma Anti Phospholipid Antibodies in Patients with Autoimmune Haemolytic Anaemia Correlate with Reduced Levels of Erythrocyte Complement Receptor 1?
P2860
Q30427395-CD5C2031-4CB7-4B1B-BB1F-EE1C7F95FCEEQ30449835-852467EF-3A92-4658-8A54-609FD93A50ACQ34731255-68B7AE6E-1A1F-43A1-896C-E0DAF0F0F930Q35222830-9A2E6849-722C-4873-9D7E-54DC4A1A77EFQ35824467-4EC147E2-764C-4DB0-AB52-B0E6AD20CC75Q36171508-382A7643-1E7B-48F9-B68E-4F6032A27DEDQ36228761-F8569C45-2479-4C08-8430-3257C6AA9CD8Q36572977-32583FD9-9BD3-4AF9-B086-F3904C553750Q38694115-9DA1B3A2-3D8E-4785-8310-A8C7C5A77D37Q39486877-75A2687B-2EC5-4359-A4F3-6E64AD1A65E2Q40552933-FCED2EF3-3F91-4FA0-ACCD-1B578D33D22BQ40706471-2EB2B560-5063-42AC-BCE2-DFDD4F1E41EDQ41244545-2D118649-8C74-4ED3-A6B1-94B7EF5C08A7Q41896275-009B19F2-45C9-4E5B-8C2E-81D130A5D132Q46938672-6BC22C6B-94D0-4CFA-ADF9-D6C02A342B36Q47972761-59441B20-A3D0-4D07-B192-EE79CAB3A1B8Q56832415-FD54B05A-7ED1-4366-BA1B-B8DF83BDF796
P2860
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
description
1988 nî lūn-bûn
@nan
1988 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@ast
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@en
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@nl
type
label
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@ast
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@en
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@nl
prefLabel
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@ast
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@en
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@nl
P356
P1476
Erythrocyte complement receptor type 1, immune complexes, and the rheumatic diseases.
@en
P2093
Lachmann PJ
P304
P356
10.1002/ART.1780310201
P50
P577
1988-02-01T00:00:00Z